CA Treasurer Seeks AIDS Drug Price Cuts from Gilead, Others

In Letters to CEOs of Eight AIDS Drug Companies, Lockyer States "The State Cannot Keep Up with Both the Increasing Demand and Rising Drug Costs in the ADAP Program" SACRAMENTO, Calif., Apr 11, 2011 (BUSINESS WIRE) -- --Thousands Across U.S. Denied Access...